News | June 02, 2023
Evonik launches next-generation peptide for biopharma applications
One thousand times more soluble than L-cystine at neutral pH
One thousand times more soluble than L-cystine at neutral pH
These initiatives aim to improve access to healthcare for rare disease patients
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
The collaboration between CORONA and Ferring will cater to patients across India
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.
For the year 2022, Biocon bettered its score in all the four EcoVadis themes – Environment (70), Labor & Human Rights (70), Ethics (60), and Sustainable Procurement (60)
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
Subscribe To Our Newsletter & Stay Updated
